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Introduction: Merkel cell carcinoma (MCC) or cutaneous neuroendocrine carcinoma is a rare and 
aggressive cutaneous malignancy. Interestingly, despite its aggressive nature, complete spontaneous 
regression of MCC has been reported, mostly of the head and neck sites, and after biopsy or 
fine-needle aspiration sampling. There has been speculation that the biopsy of MCC may trigger 
complete spontaneous tumor regression via stimulation of the immune system. Spontaneous 
regression of metastatic MCC lesions after the excision of the main lesion, however, has not been 
reported in English literature.  
Presentation of case: We report an extremely rare case of MCC of the left gluteal region with left 
inguinal lymphadenopathy and metastatic dermal nodules who underwent excision of the main lesion 
and was noted to have spontaneous regression of his dermal metastases post-operatively. 
Conclusions: Spontaneous regression of MCC remains a poorly understood phenomenon. Further 
research into the histopathological features and immunity status should be considered to elucidate 
the mechanism underlying this phenomenon, as it will potentially be life-saving for patients with this 
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Introduction 
Merkel cell carcinoma(MCC) is a rare and aggressive cutaneous malignancy. First described in 
1972 by Cyril Toker as “trabecular carcinoma of the skin,” it is also known as neuroendocrine 
carcinoma or small cell carcinoma of cutaneous origin [1].The 5-year disease-specific survival of 
MCC is reportedly between 56% to 64% and a mere 0% to 18% for those with metastatic disease at 
presentation [2, 3]. Interestingly, despite its aggressive nature, complete spontaneous regression of 
MCC has been reported [3, 4]. A rare and poorly understood phenomenon, it was first described in 
1986 by O'Rourke and Bell [5]. Subsequently, sporadic cases of spontaneous regression have been 
described, with the largest single series of ten cases by Connelly et al. in 2000 [6]. Majority of 
these cases has been MCC of head and neck sites. In this article, we report an extremely rare case 
of MCC of the left gluteal region with left inguinal lymphadenopathy and metastatic dermal 
nodules who underwent excision of the main lesion and was noted to have spontaneous regression 
of his dermal metastases post-operatively. 
Case Presentation 
An 86-year old Chinese gentleman presented in January 2014 with a gradually-enlarging left 
gluteal lump. He denied any bleeding, pain or itch and had no constitutional symptoms. The patient 
sought medical attention as the enlarging lesion had caused him discomfort on sitting. On 
examination, a large exophytic mass measuring approximately 6cm by 6cm was seen over his left 
gluteal region. There was palpable left inguinal lymphadenopathy. No other lesions were noted. 
 
 
Figure 1 MRI showing a T2-hyperintense 5.2cm by 5.8cm by 1.9cm mass in the left gluteal region with left inguinal 
lymphadenopathy 
 
Trucut biopsy of the gluteal lesion revealed neuroendocrine carcinoma which stained diffusely and 
strongly for pankeratins, Epithelial Membrane Antigen (EMA), synaptophysin and CD56. Fine 
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needle aspiration of the left inguinal lymphadenopathy returned as metastatic carcinoma. The 
patient then underwent magnetic resonance imaging (MRI) which showed a 5.2cm by 5.8cm by 
1.9cm lobulated mass over the left gluteal region with extension into the underlying subcutaneous 
tissues but no obvious involvement of the gluteus muscles. Multiple enlarged lymph nodes were 
seen in the left inguinal region (Figure 1).  Computed tomography of the chest, abdomen and 
pelvis were negative for metastases. After discussion at a multidisciplinary Sarcoma Board, 
curative surgical resection with lymphadenectomy was recommended. The patient then underwent 
pre-operative evaluation for his multiple medical comorbidities including hypertension, 
hyperlipidemia and chronic renal impairment. However, despite the expedited process, multiple 
new dermal lesions which were not previously present, developed during two-month interim period 
and were noted on the day of planned surgery (Figure 2a-c). Frozen section confirmed that these 
lesions were inkeeping with tumor involvement. Curative resection was then deemed infeasible in 
view of the inability to resect all satellite lesions. The patient was re-counselled and underwent 
palliative resection of the main lesion with a view for possible adjuvant radiotherapy to the 
metastaticdermal nodules and inguinal lymphadenopathy.  
 
 
Figure 2(a) Main lesion – an exophytic purplish-red plaque over the left gluteal region, (b) Multiple dermal 
metastases, (c) Resected left gluteal tumor specimen and (d) Complete regression of dermal metastases seen at 
post-operative follow-up at 15 weeks 
Excision of the left gluteal lesion with wide margins was performed and histology returned as 
neuroendocrine carcinoma featuring nested and irregular trabecular architecture, comprised of 
uniform cells with round to ovoid nuclei, finely granular chromatin with indistinct nucleoli, scant 
cytoplasm and frequent mitoses. The tumor cells stained diffusely positive for low molecular 
weight cytokeratin CAM 5.2 as well as synaptophysin.  
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Post-operative recovery was uneventful. Interestingly, at outpatient review two-month 
post-operatively, all metastatic dermal nodules had spontaneously regressed. The patient declined 
repeat imaging to assess his inguinal lymphadenopathy but remains well with no recurrence of any 
dermal lesion (Figure 2d). 
Discussion 
MCC is an aggressive cutaneous neuroendocrine malignancy originating from Merkel cells of the 
epidermis. Merkel cells function as mechanoreceptors and are sensitive to touch [7,8]. A rare entity 
with an estimated incidence of 0.6 per 100,000 person-years, it has seen a steady increase in recent 
years due in large part to improved detection as well as an increase in the prevalence of patients 
harboring risk factors for the disease. These include fair skin, elderly age, ultraviolet (UV) light 
exposure and immunosuppression [9]. Heath et al. previously summarized the clinical features of 
this condition using the acronym “AEIOU”: Asymptomatic/lack of tenderness, Expanding rapidly 
(≤ 3 months), Immunosuppression, Older than age 50, and location on a UV-exposed site [10]. In 
2008, Feng et al. identified a new human polyomavirus (Merkel cell polyomavirus, MCPyV) 
involved in the pathogenesis of MCC [11]. Subsequent studies have suggested that integration of 
the polyomaviral DNA into host DNA precedes tumorigenesis, rendering strength to the hypothesis 
of an infectious etiology[12, 13]. 
 
MCC frequently presents as a red or violaceous cutaneous lesion and predilection for head and neck 
sites has been well-documented [2, 10]. With a propensity for spread via dermal lymphatics, many 
patients present with satellite lesions at the point of diagnosis. Our patient did not have dermal 
metastases at the point of presentation but rapidly developed them over the short course of 
pre-operative evaluation, consistent with the known aggressive nature of MCC. 
 
Spontaneous regression of MCC is an extremely rare phenomenon and was first reported in 1986 
[5]. To date, majority of reported cases are of the head and neck sites. An extensive English 
literature search on PubMed revealed no prior reports of spontaneous regression of extremity 
dermal metastases after resection of the main lesion. To the best of our knowledge, our patient is 
the first-ever reported case of such a phenomenon.  
 
There has been speculation that the biopsy of MCC may trigger tumor regression via stimulation of 
the immune system. Immune reconstitution in previously immunocompromised patients with MCC 
leading to spontaneous regression of MCC has also been reported [14, 15]. Supporting this 
hypothesis that the immune system plays a critical role in MCC regression, histopathologic studies 
have demonstrated lesion infiltration by CD4+, CD8+, and CD3+ T lymphocytes and macrophages, 
suggesting that T-cell-mediated immunity plays an important role in tumor regression [16-18]. 
Apoptotic events have also been reported to play an important role in spontaneous regression [19]. 
Conclusion 
Spontaneous regression of MCC remains a poorly understood phenomenon. Further research into 
the histopathological features and immunity status should be considered to elucidate the mechanism 
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underlying this phenomenon, as it will potentially be life-saving for patients with this rare 
malignancy, whose median survival will otherwise be measured in months. 
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